US Patent 10081661 Methods and compositions for genome engineering
Patent 10081661 was granted and assigned to Sangamo Therapeutics on September, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+204 characters)
Article
Patent abstract
Disclosed herein are methods and compositions for insertion of transgene sequences encoding proteins that is aberrantly expressed in disease or disorder such as a lysosomal storage disease.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
David Paschon0
Edward J. Rebar0
Jeffrey C. Miller0
Lei Zhang0
Thomas Wechsler0
Edits on 12 Apr, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Dec, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Aug, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10081661 Methods and compositions for genome engineering
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10081661
Date of patent
September 25, 2018
Patent application number
14565014
Date Filed
December 9, 2014
Patent primary examiner
Find more entities like US Patent 10081661 Methods and compositions for genome engineering
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
